- Trials with a EudraCT protocol (901)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (56)
901 result(s) found for: vaccines.
Displaying page 1 of 46.
EudraCT Number: 2015-000133-70 | Sponsor Protocol Number: V130_03 | Start Date*: 2015-01-09 |
Sponsor Name:Novartis Vaccines and Diagnostics, Inc | ||
Full Title: A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based... | ||
Medical condition: Prophylaxis of A Three Influenza Vaccines in Children Ages 4 Years Old to Less Than 18 Years Old | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2007-003339-22 | Sponsor Protocol Number: V70P2E1 | Start Date*: 2007-10-11 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: A Phase II, Observer-Blind, Parallel Groups, Single-Center, Extension Study to Evaluate the Immunogenicity and Safety Following a Single Intramuscular Dose of FLUAD or Vaxigrip Influenza Vaccines i... | ||
Medical condition: Influenza | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002871-15 | Sponsor Protocol Number: V58P13 | Start Date*: 2007-09-14 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: A Phase III, Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Assess Clinical Efficacy of a Cell-Derived Subunit Influenza Vaccine and an Egg-Derived Subunit Influenza Vaccine i... | ||
Medical condition: Influenza disease. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012591-27 | Sponsor Protocol Number: VAC037 | Start Date*: 2009-11-16 |
Sponsor Name:University of Oxford | ||
Full Title: A phase I/IIa study to assess the safety and immunogenicity of new malaria vaccine candidates AdCh63 MSP1 alone and with MVA MSP1 | ||
Medical condition: Plasmodium Falciparum Malaria | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004498-17 | Sponsor Protocol Number: V71_18 | Start Date*: 2014-11-13 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: A Multi-center, Phase III, Randomized, Observer Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Trivalent Subunit Inactivated Influenza Vaccine (Agriflu™) in Healthy Child... | ||
Medical condition: Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-004543-12 | Sponsor Protocol Number: V70P6 | Start Date*: 2014-11-04 |
Sponsor Name:Novartis Vaccines and Diagnostics Srl. | ||
Full Title: A Phase II, Observer-Blind, Randomized, Multi-center Study to Evaluate the Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Fluad® and Fluzone® Influenza Vaccines in Healthy Children Age... | ||
Medical condition: Influenza | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-000475-14 | Sponsor Protocol Number: V59_38 | Start Date*: 2011-10-25 | |||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | |||||||||||||
Full Title: A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines when Administered Concomitantly with Novartis Meningococcal ACWY Conjugate Vaccine in He... | |||||||||||||
Medical condition: Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines when Administered Concomitantly with Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Adults | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001223-13 | Sponsor Protocol Number: V58_31 | Start Date*: 2014-12-03 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: A Phase III, Observer-blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture or in Embryonated Ch... | ||
Medical condition: Prophylaxis: Influenza | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2016-003210-27 | Sponsor Protocol Number: 201663 | Start Date*: 2017-07-20 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase IIIA, randomized, single-blind, multi-centric study to evaluate the immunogenicity, reactogenicity and safety of three doses of Pediarix, Hiberix and Prevenar 13 when co-administered with t... | ||
Medical condition: PCV-free HRV vaccine is indicated to prevent gastroenteritis (GE) caused by rotavirus (RV) | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-018603-29 | Sponsor Protocol Number: V70_25S | Start Date*: 2010-05-17 | |||||||||||
Sponsor Name:NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. | |||||||||||||
Full Title: A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD Surface Antigen, Inactivated, Adjuvanted with MF59C.1 Influenza Vaccine, Formulation 2010-201... | |||||||||||||
Medical condition: Influenza poses a significant threat to individual and public health, and influenza vaccination with a trivalent inactivated influenza vaccine is widely recommended to children, adults at risks and... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005128-91 | Sponsor Protocol Number: V71_21 | Start Date*: 2014-11-26 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: Evaluating the safeness of Agrippal® S1 in preventing flu on Vietnamese volunteers. | ||
Medical condition: Prophylaxis for seasonal flu. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-003167-30 | Sponsor Protocol Number: 112679 | Start Date*: 2015-04-22 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A randomised, open-label study to assess the immunogenicity and reactogenicity of GSK Biologicals’ IPV vaccine administered as a three-dose primary vaccination course at 2-3-4 months of age in heal... | ||
Medical condition: Primary immunisation of healthy infants in the first year of life against poliomyelitis | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-004497-24 | Sponsor Protocol Number: 106227, 106228, 108736, 108738 | Start Date*: 2006-10-24 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: Observer-blinded, randomised, controlled, phase I/II study, to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ candidate tuberculosis vaccines M72/AS01B and M72/AS02A wh... | ||
Medical condition: Vaccination against tuberculosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002083-13 | Sponsor Protocol Number: HPVfollowup | Start Date*: 2016-07-21 | |||||||||||
Sponsor Name:Public Health England | |||||||||||||
Full Title: An observational follow up study of a randomised parallel group phase IV study to evaluate the duration of the immune response to vaccine and non-vaccine HPV types in UK adolescent females who rece... | |||||||||||||
Medical condition: No specific medical condition - immune reponses to HPV vaccination. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000085-38 | Sponsor Protocol Number: V70_39S | Start Date*: 2012-03-08 | |||||||||||
Sponsor Name:NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. | |||||||||||||
Full Title: A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD Surface Antigen, Inactivated, Adjuvanted with MF59C.1 Influenza Vaccine, Formulation 2012-201... | |||||||||||||
Medical condition: Clinical Trial on healthy volunteers (Active immunisation against influenza in the elderly (65 years of age and over), especially for those with an increased risk of associated complications (i.e. ... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004416-66 | Sponsor Protocol Number: VAC052 | Start Date*: 2012-11-26 |
Sponsor Name:University of Oxford | ||
Full Title: A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches using the ChAd63 and MVA vectors encoding the antigens ME-TRAP, CS and AMA1. | ||
Medical condition: Plasmodium falciparum Infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005871-14 | Sponsor Protocol Number: V87P1 | Start Date*: 2006-01-30 | |||||||||||
Sponsor Name:CHIRON | |||||||||||||
Full Title: A Phase II, Randomized, Controlled, Observer-blind, Multi-Center Study to Evaluate Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two FLUAD-like Surface Antigen Adjuvan... | |||||||||||||
Medical condition: Active influenza immunization pandemic strains | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015997-36 | Sponsor Protocol Number: 113809 | Start Date*: 2009-10-08 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase III, double-blind, randomized, study in adults aged between 18 and 60 years to assess the immunological non-inferiority of two manufacturing processes of the A/California/7/2009 (H1N1)v-lik... | ||
Medical condition: Immunization against A/California/7/2009 (H1N1)v-like influenza in male and female subjects aged 18 to 60 years. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005159-24 | Sponsor Protocol Number: M37P2 | Start Date*: 2014-12-23 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: A Phase III, observer-blind, randomized, controlled, multi-center study to inventigate the immunogenicity and safety of the Vaxem Hib™ in 2-4 months old healthy infants in China, according to the r... | ||
Medical condition: Invasive Haemophilus influenzae type b disease | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-005105-20 | Sponsor Protocol Number: V48P4E3 | Start Date*: 2014-11-28 |
Sponsor Name:Novartis Vaccines and Diagnostics | ||
Full Title: A phase IV, uncontrolled, open-label, multi-center study in children and adolescents: Evaluation of long-term immunogenicity in subjects boosted with a new pediatric TBE vaccine (free of protein-de... | ||
Medical condition: Prophylaxis: Tick-borne-encephalitis | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.